BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 36548440)

  • 41. miR-589-5p Inhibits Cell Proliferation by Targeting Histone Deacetylase 3 in Triple Negative Breast Cancer.
    Rahbari R; Rahimi K; Rasmi Y; Khadem-Ansari MH; Abdi M
    Arch Med Res; 2022 Jul; 53(5):483-491. PubMed ID: 35840467
    [TBL] [Abstract][Full Text] [Related]  

  • 42. MiR-140-5p inhibits cell proliferation and metastasis by regulating MUC1 via BCL2A1/MAPK pathway in triple negative breast cancer.
    Yu B; You W; Chen G; Yu Y; Yang Q
    Cell Cycle; 2019 Oct; 18(20):2641-2650. PubMed ID: 31411515
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Tumor tissue microRNA expression in association with triple-negative breast cancer outcomes.
    Liu Y; Cai Q; Bao PP; Su Y; Cai H; Wu J; Ye F; Guo X; Zheng W; Zheng Y; Shu XO
    Breast Cancer Res Treat; 2015 Jul; 152(1):183-191. PubMed ID: 26062749
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Circ_0000520 contributes to triple-negative breast cancer progression through mediating the miR-1296/ZFX axis.
    Zhou Y; Ma G; Peng S; Tuo M; Li Y; Qin X; Yu Q; Kuang S; Cheng H; Li J
    Thorac Cancer; 2021 Sep; 12(18):2427-2438. PubMed ID: 34324278
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The long noncoding RNA sONE represses triple-negative breast cancer aggressiveness through inducing the expression of miR-34a, miR-15a, miR-16, and let-7a.
    Youness RA; Hafez HM; Khallaf E; Assal RA; Abdel Motaal A; Gad MZ
    J Cell Physiol; 2019 Nov; 234(11):20286-20297. PubMed ID: 30968427
    [TBL] [Abstract][Full Text] [Related]  

  • 46. LncRNA WEE2-AS1 promotes proliferation and inhibits apoptosis in triple negative breast cancer cells via regulating miR-32-5p/TOB1 axis.
    Wang R; Huang Z; Qian C; Wang M; Zheng Y; Jiang R; Yu C
    Biochem Biophys Res Commun; 2020 Jun; 526(4):1005-1012. PubMed ID: 32307083
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Downregulation of miR-205 contributes to epithelial-mesenchymal transition and invasion in triple-negative breast cancer by targeting HMGB1-RAGE signaling pathway.
    Wang L; Kang FB; Wang J; Yang C; He DW
    Anticancer Drugs; 2019 Mar; 30(3):225-232. PubMed ID: 30334817
    [TBL] [Abstract][Full Text] [Related]  

  • 48. miR-124 regulates EMT based on ZEB2 target to inhibit invasion and metastasis in triple-negative breast cancer.
    Ji H; Sang M; Liu F; Ai N; Geng C
    Pathol Res Pract; 2019 Apr; 215(4):697-704. PubMed ID: 30611621
    [TBL] [Abstract][Full Text] [Related]  

  • 49. UBE2C, Directly Targeted by miR-548e-5p, Increases the Cellular Growth and Invasive Abilities of Cancer Cells Interacting with the EMT Marker Protein Zinc Finger E-box Binding Homeobox 1/2 in NSCLC.
    Jin D; Guo J; Wu Y; Du J; Wang X; An J; Hu B; Kong L; Di W; Wang W
    Theranostics; 2019; 9(7):2036-2055. PubMed ID: 31037155
    [No Abstract]   [Full Text] [Related]  

  • 50. miR-365 inhibits cell invasion and migration of triple negative breast cancer through ADAM10.
    Liu F; Zhuang L; Wu R; Li D
    J BUON; 2019; 24(5):1905-1912. PubMed ID: 31786854
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [miR-93-5p promotes invasion and migration of triple negative breast cancer cells by targeting FGD5].
    Zhou D; Bai J; Hu Y; Zhang L; Zheng Q; Zhong W; Mu Q; Li H; Lyu S; Yin C
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2020 Sep; 36(9):794-801. PubMed ID: 32967763
    [TBL] [Abstract][Full Text] [Related]  

  • 52. lncRNA GAS5-promoted apoptosis in triple-negative breast cancer by targeting miR-378a-5p/SUFU signaling.
    Zheng S; Li M; Miao K; Xu H
    J Cell Biochem; 2020 Mar; 121(3):2225-2235. PubMed ID: 31692053
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Long non-coding RNA SNHG8 enhances triple-negative breast cancer cell proliferation and migration by regulating the miR-335-5p/PYGO2 axis.
    Qian J; Lei X; Sun Y; Zheng L; Li J; Zhang S; Zhang L; Li W; Shi J; Jia W; Tang T
    Biol Direct; 2021 Aug; 16(1):13. PubMed ID: 34362407
    [TBL] [Abstract][Full Text] [Related]  

  • 54. LncRNA MEG3 negatively modified osteosarcoma development through regulation of miR-361-5p and FoxM1.
    Shen B; Zhou N; Hu T; Zhao W; Wu D; Wang S
    J Cell Physiol; 2019 Aug; 234(8):13464-13480. PubMed ID: 30624782
    [TBL] [Abstract][Full Text] [Related]  

  • 55. MicroRNA-33a-5p overexpression sensitizes triple-negative breast cancer to doxorubicin by inhibiting eIF5A2 and epithelial-mesenchymal transition.
    Guan X; Gu S; Yuan M; Zheng X; Wu J
    Oncol Lett; 2019 Dec; 18(6):5986-5994. PubMed ID: 31788073
    [TBL] [Abstract][Full Text] [Related]  

  • 56. miR-720 is a downstream target of an ADAM8-induced ERK signaling cascade that promotes the migratory and invasive phenotype of triple-negative breast cancer cells.
    Das SG; Romagnoli M; Mineva ND; Barillé-Nion S; Jézéquel P; Campone M; Sonenshein GE
    Breast Cancer Res; 2016 Apr; 18(1):40. PubMed ID: 27039296
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Circular RNA circ-ERBB2 Elevates the Warburg Effect and Facilitates Triple-Negative Breast Cancer Growth by the MicroRNA 136-5p/Pyruvate Dehydrogenase Kinase 4 Axis.
    Huang Y; Zheng S; Lin Y; Ke L
    Mol Cell Biol; 2021 Sep; 41(10):e0060920. PubMed ID: 34370552
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Turmeric Inhibits MDA-MB-231 Cancer Cell Proliferation, Altering miR-638-5p and Its Potential Targets.
    Kaya M; Abuaisha A; Suer I; Emiroglu S; Abanoz F; Palanduz S; Cefle K; Ozturk S
    Eur J Breast Health; 2024 Apr; 20(2):102-109. PubMed ID: 38571691
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A loop involving NRF2, miR-29b-1-5p and AKT, regulates cell fate of MDA-MB-231 triple-negative breast cancer cells.
    De Blasio A; Di Fiore R; Pratelli G; Drago-Ferrante R; Saliba C; Baldacchino S; Grech G; Scerri C; Vento R; Tesoriere G
    J Cell Physiol; 2020 Feb; 235(2):629-637. PubMed ID: 31313842
    [TBL] [Abstract][Full Text] [Related]  

  • 60. MicroRNA-200c Inhibits the Metastasis of Triple-Negative Breast Cancer by Targeting ZEB2, an Epithelial-Mesenchymal Transition Regulator.
    Chen H; Li Z; Zhang L; Zhang L; Zhang Y; Wang Y; Xu M; Zhong Q
    Ann Clin Lab Sci; 2020 Jul; 50(4):519-527. PubMed ID: 32826250
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.